Therapeutic Classes/Interleukin-6 Receptor Antagonist

Interleukin-6 Receptor Antagonist

6 drugs across 3 manufacturers|0 Generic,6 Brand

The Interleukin-6 Receptor Antagonist class contains 6 NDCs from 3 manufacturers (0 generic, 6 brand), at an average NADAC of $1343.94 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.

Total Drugs

6

0G / 6B

Manufacturers

3

Avg $1343.9404/unit

Avg 7d Change

+0.11%

Across 3 drugs with changes

7d Activity

33 flat

of 6 total drugs

Class Price Trend

Monthly average NADAC price per unit, split by generic and brand

Drug Portfolio

6 drugs total, 6 shown

Drug Price 7d Change
KEVZARA 200 MG/1.14 ML PEN INJ
sarilumab
$2074.9884
per ML
+0.18%
KEVZARA 200 MG/1.14 ML SYRINGE
sarilumab
$2066.4821
per ML
ACTEMRA ACTPEN 162 MG/0.9 ML
tocilizumab
$1279.0578
per ML
ACTEMRA 162 MG/0.9 ML SYRINGE
tocilizumab
$1001.1205
per ML
TYENNE 162 MG/0.9 ML AUTOINJCT
Tocilizumab-aazg
$820.9968
per ML
+0.04%
TYENNE 162 MG/0.9 ML AUTOINJCT
Tocilizumab-aazg
$820.9968
per ML
+0.04%

Frequently Asked Questions

How many drugs are in the Interleukin-6 Receptor Antagonist class?

The Interleukin-6 Receptor Antagonist class contains 6 NDCs from 3 manufacturers — 0 generic and 6 brand products.

What is the average price of Interleukin-6 Receptor Antagonist drugs?

The average NADAC for the Interleukin-6 Receptor Antagonist class is $1343.9404 per unit across 6 NDCs.

Which manufacturers make Interleukin-6 Receptor Antagonist drugs?

3 manufacturers make drugs in the Interleukin-6 Receptor Antagonist class. Ranked by number of NDCs, the largest are Sanofi-Aventis U.S. LLC (2), Genentech, Inc. (2), Fresenius Kabi USA, LLC (2).

How has Interleukin-6 Receptor Antagonist pricing changed recently?

Over the past 7 days, 3 NDCs in this class rose and 0 fell, with a class-wide average change of +0.1%.